Introduction
============

It is important for policy makers to understand that allocating more funds to healthcare spending is associated with improvements in health outcomes. In fact, if funds are allocated to building healthcare facilities in rural areas where there had been no access, and efforts are made to reduce waiting time in hospitals, a significant heath outcome will result. Equally, an increase in government expenditure for preventive or curative care, nutrition activities, emergency aid and immunization are expected to have a considerable effect on reducing mortality. Consequently, questions remain about the relationship between health spending and health outcomes, especially with rising healthcare costs. In this study, total healthcare expenditure is disaggregated into public and private healthcare expenditure (both as percentages of gross domestic product). Public healthcare expenditure consists of recurrent and capital spending from government budget and from external borrowing and grants, as well as from social health insurance funds. Private healthcare expenditure includes direct, household out-of-pocket spending, private insurance, charitable donations and direct service payments by private corporations[@R1]. According to the WHO, public health expenditure is higher in advanced and middle-income countries, and in low-income countries private healthcare expenditure is higher. This reveals that out-of-pocket expenditure makes up the largest proportion of private health expenditure. In fact, high out-of-pocket expenditure may create a burden for households to access healthcare services, which is a primary issue in third-world countries[@R2].

Over the past 15 years, both public and private healthcare expenditure has risen in the eight African countries examined in this study. This increase in spending has corresponded with an improvement in several health status indicators. [Table 1](#T1){ref-type="table"} shows the change in health status indicators and healthcare expenditure for eight African countries from 2000 to 2014. In almost all the countries, there has been a reduction in the mortality rate, maternal deaths, prevalence of HIV and incidence of tuberculosis. The highest reduction in female adult mortality was achieved in Tanzania (47%), and the highest reduction in male adult mortality was achieved in Rwanda (50%). Rwanda also experienced the highest reduction in maternal deaths (65%). The highest reduction in the incidence of tuberculosis was observed in Uganda (62%). The prevalence of HIV has been reduced in most of the countries, with the highest reduction in Burundi (0.67%). It is worth mentioning that this selected Africa region experiences civil and cross-border war. Most of the eight selected countries have witnessed either political turmoil or civil war in the past. Due to missing information, we did not include countries such as Djibouti, Somalia or South Sudan. The government and policy makers of the eight countries included in this study paid little or no attention to the development of their health sector in the past due to having to focus attention on resolving political instability, social security issues and various other crises. Today, the story is changing as these governments and policy makers are seen to be striving to improve and allocate more funds to the health sector for proper growth and development of the sector. For example, looking at [Table 1](#T1){ref-type="table"}, there has been a greater change in healthcare expenditure and health outcomes for almost all countries except Eritrea, where total healthcare expenditure declined, and progress in health outcomes was recorded. Most of the countries in our research study do not have enough capacity to raise funds publicly as revenues due to their informal running system, which makes collection of the tax very difficult, hence limiting and causing serious constraints on healthcare investments. Therefore, for this gap to be bridged, the government must prioritize the allocation of resources through innovative means towards healthcare spending. Although external aids and funds remain very relevant in all aspects, the government must ensure effective and improved flows of funds by harmonizing resource allocation towards health spending as a national priority[@R3]. We believe it is necessary to examine the effect of healthcare expenditure, and this study aims to use empirical work to provide evidence of an association between healthcare expenditures and health outcomes, positive or negative. Without doubt, Sub-Saharan Africa is one of the most affected regions in mortality and HIV incidence in the world. It is critical for governments in these countries and health sector strategists to understand to what extent health expenditure must increase to bring the desired health outcomes[@R4].

###### 

Health Status and Healthcare Expenditure in Eight Selected African Countries

  Variable   Burundi   Eritrea   Ethiopia   Kenya     Rwanda    Tanzania   Sudan     Uganda
  ---------- --------- --------- ---------- --------- --------- ---------- --------- ---------
  MRAF       --18.61   --31.88   --44.48    --44.70   --42.06   --46.80    --20.51   --43.00
  MRAM       --14.46   --30.11   --37.56    --37.33   --50.02   --38.85    --20.10   --36.35
  NMD        25.00     --4.17    --53.85    --9.89    --65.63   --29.17    --31.15   --19.44
  TU         --56.55   --55.93   --50.83    --13.99   --35.71   --34.99    --26.56   --62.30
  PHIV       --0.67    --0.61    --0.63     --0.46    --0.47    --0.33     1.00      --0.01
  HEPT       --0.34    --36.37   1.78       --11.91   81.58     99.91      183.42    9.84
  HEPP       182.96    --3.84    20.35      61.71     73.57     126.01     103.11    --2.00
  HE         51.37     --24.72   11.92      22.16     78.44     111.23     161.32    6.63

Mortality rate, adult, female (per 1,000 female adults) (MRAF); Mortality rate, adult, male (per 1,000 male adults) (MRAM); Number of maternal deaths (NMD) (per 100,000 people)); Incidence of tuberculosis (per 100,000 people) (TU); Prevalence of HIV, (total % of population age 15--49) (PHIV); HEPT (private healthcare expenditure), HEPP (Public healthcare expenditure) and Total Healthcare expenditures (HE).

A growing body of empirical and conceptual studies examine the relationship between healthcare spending and health status, however, a consensus has not been reached. Among these studies, some researchers consider total healthcare expenditure as a determinant of health status, while other researchers concentrate on its components: public health expenditure and private health expenditure. Anton and Onofrei[@R4] used the Ordinary Least Squares (OLS) method to study the relationship between total healthcare expenditure and under-five mortality rates for Central and Eastern European countries. Their study showed that a one percentage point increase in total expenditure is associated with a 0.64% reduction in the under-five mortality rate. Anyanwu and Erhijakpor[@R5] examined the relationship between total health expenditure and public healthcare expenditure on health outcomes (infant and under-five mortality). Their study revealed that for Sub-Saharan African countries, there is a positive and significant association with infant and under-five mortality. Heijink et al.[@R6] studied the relationship between private and public health expenditure for 14 Western countries for the period 1996 to 2006 and argued that total healthcare expenditure is associated with reducing avoidable mortality. Other researchers have studied the relationship and provide evidence that there is a positive association[@R7]--[@R14]. Nevertheless, some researchers argue that there is no relationship. For example, a study by Lippi et al.[@R15], investigating the association between healthcare expenditure and mortality rates for the European Union using the Spearman correlation method, revealed there is no relationship between healthcare expenditure and mortality rates. In line with this finding, Mackenbach[@R16] documented that there is no association between healthcare expenditures and decreasing mortality rates. Along with this study, some researchers found statistically insignificant relations or documented limited relationships[@R17]--[@R19].

A good amount of literature has explored healthcare expenditure by separating public and private healthcare spending. Several studies have suggested that public healthcare expenditure reduces mortality and increases life expectancy.[@R20]--[@R25] Using an error correction model, researchers found that the relationship between public health expenditure and life expectancy in Lesotho was significant and positive as seen in the results of the life expectancy at birth (years), infant mortality rate (per 1,000 live births), and under-five mortality rate (per 1,000)[@R20]. Bokhari and Gottret[@R21] also showed that public healthcare expenditure positively contributed to a reduction in under-five mortality and maternal mortality. On the other hand, researchers showed that there is little to no relationship between public healthcare spending and health outcomes[@R26]--[@R30].

Among these studies, Zakir and Wunnaya[@R26] studied the relationship between public healthcare expenditure and mortality in 1993 for 117 countries. The researchers found that public healthcare expenditure does not have a major effect on reducing infant mortality rates. A study by Berger and Messer[@R28], using a sample study running from 1960 to 1992 for 20 Organisation for Economic Co-operation and Development (OECD) countries, showed that an increase in public healthcare expenditure increases mortality rates. Filmer and Pritchett[@R30] showed that government healthcare expenditure has a limited effect on under-five mortality.

Additionally, some studies consider the impact of private healthcare expenditure together with public expenditure[@R31]--[@R36]. Aisa et al[@R31], showed that public healthcare expenditure has a higher impact on life expectancy than private expenditure. Homaie et al.[@R34] carried out a panel study of Eastern Mediterranean countries and showed that while public healthcare expenditure has a negative impact on infant mortality, private expenditure has a positive impact. This study was limi***ted, however, since only the variable of infant mortality was analyzed.*** Issa and Ouattara[@R35] showed that total healthcare expenditure is negatively related to mortality, but when differentiating between public and private spending, they found that private healthcare expenditure has a greater impact on mortality than public healthcare expenditure.

The above researchers mostly considered healthcare expenditure and its components (public and private as a percentage of gross domestic product), however, there are those who focus on per capita healthcare expenditure. For instance, in 2008, Gani[@R36] studied the relationship between per capita public healthcare expenditure and three health outcomes (infant and under-five mortality rates and crude death rate) for seven Pacific island countries using sample data from the period 1990 to 2002. His findings showed that a 10% increase in per capita healthcare expenditure is associated with a reduction of 3.6 infant deaths per 1,000 live births in a country with a high infant mortality rate. Others have also considered per capita public healthcare expenditure as a dependent health outcome[@R37].

The existing literature also emphasizes that other variables can reduce child mortality rates with or without factoring in public healthcare expenditure[@R38]--[@R41]. Within this literature, the 1997 study by Filmer and Pritchett[@R30] provided empirical support to demonstrate that public health spending is not a main driver in reducing child mortality rates. They added that variables such as income, income inequality, female education and cultural factors are important in explaining the variation in child mortality rates. In line with this, other researchers argued that factors to consider include education status of parents, females and children, and medical facilities (Kessler and McClellan[@R42], Glied and Lieras-Muney[@R43]). Other researchers such as Moore[@R44] showed that global trade and globalization reduced mortality. Wagstaff and Cleason (2004)[@R45] underline that good policy and institutional improvement provide an increase in the link between government healthcare expenditure and health outcomes (maternal mortality, underweight children, under-five mortality and tuberculosis).

Some researchers investigated how healthcare expenditure affects impoverishment and other variables. For example, Bredenkamp et al.[@R46], using data from household surveys, examined the variation in out-of-pocket expenditure for healthcare and their relationship with financial protection for Western Balkans countries. Their findings demonstrated that individual healthcare spending significantly contributes to increased poverty and making the situation worse for those who are already impoverished. Some researchers have investigated the relationship between insurance coverage and/or out-of-pocket expenditure[@R47]--[@R50].

Based on the literature on healthcare expenditure and health outcomes, we can make the following summary. Existing literature reveals that the association between healthcare expenditure and health outcomes is still in debate: some report there is no relationship, while others report a limited relationship. Besides this, most of the literature focuses on non-African countries, even though the region is one of the most affected regions in the world. Studies that investigate public and private healthcare expenditure are very rare. Lastly, studies that examine the association between maternal deaths and the prevalence of HIV and health expenditure are limited, as most of the literature focuses on under-five mortality and mortality rates. Therefore, this paper adds to the body of available evidence on the relationship between healthcare expenditure and the following health variables: incidence of tuberculosis, male and female mortality rates, number of maternal deaths and the prevalence of HIV in eight selected African countries, and whether the contribution of public healthcare expenditure is more significant than private healthcare expenditure.

This study differs from the existing literature on healthcare spending and health outcomes in the following ways. First, we make use of time series and strong, balanced data to examine the association with a total of 112 observations. Second, previous research on African countries, such as the study by Anyanwu and Erhijakpor[@R5], focuses on infant and under-five mortality. In this study, we paid attention to four health outcome variables, namely incidence of tuberculosis, adult mortality rate, number of maternal deaths per year and prevalence of HIV. The study also examines whether health spending has a different relationship based on gender; this is important to understand if females are equal to males in healthcare spending. According to Gao and Yao[@R52], men have access to less health spending than women, although they earn more. Irving and Kingdom[@R51], based on their interest in curative healthcare, made sequential observations on gender differences on healthcare based on health spending, state of health and consultation. Their results found: fırst, women tend to report states of ill health with higher frequency than men making their expenditure higher; second, women consult healthcare providers (doctors, physicians, etc.) more readily than men do, keeping them healthier; third, on consultation reports, the rate at which men and women incur positive health spending differs a lot and lastly, the average health spending analysis differs for women and for men.

According to global burden diseases (GBD)[@R53] 2015 report, mortality levels for individuals that are HIV infected have different mortality rates; for children, adult male and adult female for the affected population. The female HIV infected population are higher than the others according to Aaron et al.[@R54]. Also, based on life expectancy, it was also observed that women live longer than men with a gap of 4.6 years approximately according to the Human Development Index[@R55]. It is worth remembering that two goals from the United Nations\' (UN\'s) agenda for sustainable development are gender equality and ensuring healthy lives for all[@R56]. In addition, previous research highlights that the mortality rate is high among females and also that healthcare spending is different between genders[@R57]--[@R59]. Third, the existing literature did not investigate healthcare spending by separating public healthcare and private healthcare expenditures on health outcomes for selected African countries. This is important since the WHO reveals that in advanced and middle-income countries, public health expenditure is higher, whereas in low-income countries private health expenditure is higher.

The paper documents that there is a statistically significant association between healthcare spending (public and private) and health status. Public healthcare expenditure has a higher association with reducing the adult mortality rate, tuberculosis and HIV than private expenditure for the average country in our sample. We also compared the association between increases in healthcare spending on males versus females and observed that public health expenditure is equal, related to the health status of both sexes. However, private health expenditure provides a greater positive benefit for males. The remainder of this paper is organised as follows. Section Two discusses the data and methodology of the study, while Section Three presents the empirical results. Finally, some concluding remarks are offered.

Data and Methodology
====================

Data and descriptive statistics
-------------------------------

World development indicator yearly data from 2000 to 2014 is used for this study. Data before 2000 is not used as HIV data for the Republic of Sudan is unavailable. [Table 2](#T2){ref-type="table"} provides a descriptive summary of all the variables utilized in this study. Variables are defined as follows. HEPT: private healthcare expenditure as a percentage of GDP; HEPP: public healthcare expenditure as a percentage of GDP; HE: total healthcare expenditure as a percentage of GDP; TU: incidence of tuberculosis per 100,000 people; MRAF: female adult mortality rate per 1,000 female adults; MRM: male adult mortality rate per 1,000 male adults; NMD: number of maternal deaths per year; and PHIV: prevalence of HIV as a percentage of the population ages 15--49. [Table 2](#T2){ref-type="table"} also provides characteristics of the data. For example, private healthcare expenditure as a percentage of GDP was highest in Burundi at 8% and lowest in Tanzania at 2%. Public healthcare expenditure as a percentage of GDP was highest in Burundi at 6%. The highest incidence of tuberculosis was found in Tanzania, at 510 per 100,000 people, while the lowest was at 63 per 100,000 people in Rwanda. The highest adult female mortality rate was in Uganda, at 496 per 1,000 people, and lowest in Rwanda at 178 per 1,000 people. For males, the highest adult male mortality was in Rwanda in 2000, at 593 per 1,000 people. This figure decreased to 296 by 2014. The lowest male mortality rate was observed in Sudan, at 254 per 1,000 people. The highest number of maternal deaths per year was 26,000 in Ethiopia in 2014; by 2014, this figure decreased to 12,000. The lowest number of maternal deaths per year was found in Eritrea, at 920. In the year 2000 in Kenya, 9.9% of the population was infected with HIV. This percentage dropped to 5.3% by 2014. Sudan is least affected by HIV, with only 0.1% of the population infected. [Table 3](#T3){ref-type="table"} shows the correlation between healthcare expenditure (total, public and private) as percentages of GDP, with several variables representing health status. Focusing on the first column, private healthcare expenditure has a negative relationship with almost all variables, with the greatest negative correlation observed with the number of maternal deaths. A positive correlation is observed with the prevalence of HIV and male mortality. This is likely because pairwise correlation does not consider variations over time or individual variations[@R60]--[@R61]. Considering the relationship between public healthcare expenditure and health status, a negative relationship is observed with almost all variables except the number of maternal deaths and prevalence of HIV. The greatest negative relationship is observed between adult female mortality and public healthcare expenditure. Total healthcare expenditure has a negative relationship with all variables except prevalence of HIV.

###### 

Descriptive Summary of Variables

  Variable   Obs   Mean    Std. Dev.   Min     Max
  ---------- ----- ------- ----------- ------- -------
  HEPT       120   3.429   1.735       1.48    7.96
  HEPP       120   2.36    0.9477      0.755   5.499
  HE         120   5.79    2.1         2.6     11.4
  TU         120   234     129         63      510
  MRAF       120   303     78          177     496
  MRAM       120   370     74          254     592
  NMD        120   7108    5931        920     26000
  PHIV       120   3.65    2.66        0.1     9.9

###### 

Pairwise Correlation between Healthcare Expenditures and Health Status

         HEPT      HEPP       HE
  ------ --------- ---------- ---------
  TU     --0.275   --0.0115   --0.226
  LTU    --0.23    --0.0152   --0.192
  MRAF   --0.019   --0.1462   --0.079
  MRAM   0.0363    --0.0626   0.0017
  NMD    --0.322   0.0759     --0.226
  LNMD   --0.141   0.1173     --0.062
  PHIV   0.0866    0.0263     0.0813

Note: LTU and LNMD are converted in to a logarithmic.

Methodology
===========

To investigate the impact of public and private healthcare expenditure on health status for eight selected African countries, we utilized two different panel data techniques: fixed and random effects. We employed two methods since each technique has some advantages over the other. The fixed model has advantages over the random model since it accounts for individual country variation, and this is important since each of the eight countries in our sample has a different healthcare system, economic structure, demographics, etc. This model removes the effect of these time-invariant characteristics which allow us to assess the net effect of the predictor on the outcome variables. Also, this model assumes that the characteristics of the time-invariant characteristics are specified to the individual, so should not have any relationship with another individual characteristic[@R62]--[@R64], the random method may be preferred over the fixed if it is believed that some variables are time-invariant and that dependent variables are random and uncorrelated with the dependent variable. Also, in random effects, we can estimate effects of the stable covariates like race and gender. Furthermore, because it uses a variation for both within as well as between individuals, the random effects technique typically has minimal sampling variability compared with fived effects[@R62]--[@R64]. Fixed and random models are suitable for this study since the data is cross-section and time series (for the eight countries and yearly data from 2000--2014). In addition, the study sample is strongly balanced data (no missing observation) with a total observation of 112. The above two methods have been used by several researchers in healthcare and social science to investigate cross-section and time series panel data. For example, researchers[@R65] & [@R66] make use of the fixed-effect model[@R65], while random methods were used by Akinci et al[@R66]. The Hausman test is carried out to choose between these two methods and mostly when the result differs. In our case, the two models yield the same results, hence this research carried out the Hausman test for each variable, and the results are reported in the empirical section. Other models such as pooled OLS are also used in healthcare and social science[@R67]. However, the model has drawbacks such as not taking heterogeneity into account[@R62].

Models 1 and 2 represent the specific equations we used.

Model 1

*Y* = *α*~*i*~ + *β*~1~ *HEPP~it~* + *ε~it~*

Model 2

*Y* = *α*~*i*~ + *β*~1~ *HEPT~it~* + *ε~it~*

In the equations, i and t represent the number of countries and time, respectively. Y represents the dependent variables MRAF, MRM, NMD, TU and PHIV. HEPP and HEPT are the independent variables. *αα*~i~ is the fixed-effect parameter that varies across individual countries but does not vary over time. Under the random effect model, all countries have a common mean value for the intercept. *ε~it~ε~it~* is the error term for each observation normally distributed with '0' mean and constant variance.[@R62]

Empirical Results
-----------------

Two panel techniques, namely fixed and random model are used to investigate the relationship between healthcare expenditure and health outcomes. Regression results are reported in [Tables 4](#T4){ref-type="table"} to [7](#T7){ref-type="table"}. In choosing which model to present we have carried out the Hausman test that is to test the null hypothesis. The random model is better against the alternative fixed model. The random model is said to be better if prob\>chi2 is above 5% and whereas the fixed is better if prob\>chi2 is below 5%. Nevertheless, in this study the estimation from both models yielded the same results and for this reason the output of the one model is reported. [Table 4](#T4){ref-type="table"} displays the results of the empirical examination of public and private healthcare expenditure on adult female and male mortality. In Panel A, considering the association between public healthcare expenditure on female and male adult mortality using random and fixed effects models respectively, one can observe that a negative and robust relationship exists between them. The results are statistically significant at 1%, and there is a negative association between both sexes\' mortality rates and public health expenditure. In other words, if a country increases its public health expenditure, the result will be a decline in adult mortality. Referencing Panel B, exploring the relationship between private healthcare expenditure on adult female and male mortality using random and fixed effects models respectively, the results reveal there is a negative relationship that is statistically significant at 1% between the two variables. Although both public and private expenditure is negatively related and statistically significant at the 1% level, the association is observed much more with public expenditure considering the different effect of healthcare expenditure on adult female and male mortality. We observed public healthcare expenditure on female adult mortality to be greater than with male adult mortality, even though both are statistically significant at the 1% level. However, private healthcare expenditure has a greater impact on male mortality than on female mortality. [Table 5](#T5){ref-type="table"} illustrates the results from analyzing the impact of public and private healthcare expenditure with the number of maternal deaths. Both Panels A and B show a negative relationship between the variables. However, the relationship between private healthcare expenditure and maternal deaths is more robust and statistically significant. In Panel B, for example, an increase in private healthcare expenditure is associated with a decline in the number of maternal deaths, the result is statistically significant at 5%. However, to understand what type private health expenditure should be encouraged, it is necessary to examine each component individually. Panel A also shows a negative association between public healthcare expenditure and maternal deaths. However, there is no statistical relationship. Additionally, the pairwise correlation test supports these results. The Hausman test reveals that the random method is better since prob\>chi2 is above 5%.

###### 

Healthcare Expenditure and Mortality Rate

  --------------------------------------------------------------------------------------------------------------------------------------
                  Panel A: (HEPP) and adult mortality rates   Panel B: (HEPT) and adult mortality rates                  
  --------------- ------------------------------------------- ------------------------------------------- -------------- ---------------
  MRAF & MRAM     Coef.                                       Coef.                                       Coef.          Coef.

  HEPP            −.0798\*\*\*                                −.06827\*\*\*                               ---            ---

                  \[.0200\]                                   \[.0181\]                                   ---            ---

  HEPT            ---                                         ---                                         −.0457\*\*\*   −.05393\*\*\*

                  ---                                         ---                                         \[.0147\]      \[.0131\]

  Intercept       5.872\*\*\*                                 6.055\*\*\*                                 5.840\*\*\*    6.079\*\*\*

                  \[.0905\]                                   \[.0448\]                                   \[.0922\]      \[.0470\]

  R-sq            0.129                                       0.113                                       0.089          0.131

  F-statistics                                                14.17\*\*\*                                                16.78\*\*\*

  Wald chi2 (1)   15.79\*\*\*                                                                             9.66\*\*\*     

  Hausman test\   0.67\                                       4.46\                                       1.32\          7.82\
  chi2\           0.4121                                      0.0346\*\*                                  0.2510         0.0052\*\*\*
  prob\>chi2                                                                                                             
  --------------------------------------------------------------------------------------------------------------------------------------

Note: \*\*\*, \*\*, and \* are statistically significant at 1%, 5% and 10% respectively.

###### 

Healthcare Expenditure and Maternal Deaths

  -----------------------------------------------------------------
                  Panel A: HEPP and LNMD   Panel B: HEPT and LNMD
  --------------- ------------------------ ------------------------
  LNMD            Coef.                    Coef.

  HEPP            -0.0356                  ---

                  \[0.0218\]               ---

  HEPT            ---                      -0.0871\*\*

                  ---                      \[0.014\]

  Intercept       8.578\*\*\*              8.793\*\*\*

                  \[0.366\]                \[0.373\]

  R-sq            0.0238                   0.02584

  Wald chi2 (1)   2.66                     39.07\*\*\*

  Hausman test\   0.08\                    0.09\
  chi2\           0.7809                   0.9741
  prob\>chi2                               
  -----------------------------------------------------------------

Note: \*\*\*, \*\*, and \* are statistically significant at 1%, 5% and 10% respectively.

###### 

Healthcare Expenditure and Prevalence of HIV

  -------------------------------------------------------------------------------------
                  Panel A: HEPP and prevalence\   Panel B: HEPT and prevalence of HIV
                  of HIV                          
  --------------- ------------------------------- -------------------------------------
  HIV             Coef.                           Coef.

  HEPP            -0.412\*\*\*                    --

                  \[0.089\]                       --

  HEPT            --                              -0.1384\*\*

                  --                              \[0.0702\]

  Intercept       4.632\*\*\*                     4.133\*\*\*

                  \[1.037\]                       \[1.049\]

  R-sq            0.1611                          0.0351

  Wald chi2 (1)   21.11\*\*                       3.88\*\*

  Hausman test\   0.21\                           0.20\
  chi2\           0.6468                          0.6552
  prob\>chi2                                      
  -------------------------------------------------------------------------------------

Note: \*\*\*, \*\*, and \* are statistically significant at 1%, 5% and 10% respectively.

###### 

Healthcare Expenditures and Tuberculosis

  ---------------------------------------------------------------------------------
                  Panel A: HEPP and tuberculosis   Panel B: HEPT and tuberculosis
  --------------- -------------------------------- --------------------------------
  tuberculosis    Coef.                            Coef.

  HEPP            -0.1212\*\*\*                    ---

                  \[0.024\]                        ---

  HEPT            ---                              -0.0351\*

                  ---                              \[0.019\]

  Intercept       5.586\*\*\*                      5.42\*\*\*

                  \[0.222\]                        \[0.220\]

  R-sq            0.179                            0.0258

  Wald chi2 (1)   23.96\*\*\*                      3.21\*

  Hausman test\   0.37\                            0.13\
  chi2\           0.5417                           0.7202
  prob\>chi2                                       
  ---------------------------------------------------------------------------------

Note: \*\*\*, \*\*, and \* are statistically significant at 1%, 5% and 10% respectively.

[Table 6](#T6){ref-type="table"} presents the results of the analysis of the impact of public and private healthcare expenditure on the prevalence of HIV as a percentage of the population age 15 to 49. Empirical results illustrate a negative relationship between both public and private healthcare spending and HIV. Public expenditure, seen in Panel A, shows a more robust and higher association with reducing HIV prevalence than private expenditure. Panel B shows a negative association between private healthcare expenditure and the prevalence of HIV. Pairwise correlation does not support this negative relationship since it does not consider individual countries\' variations; some countries have an extremely low rate of HIV while others have much higher rates. Pairwise correlation also does not consider time variations. The Hausman test reveals random is better since prob\>chi2 is above 5%.

[Table 7](#T7){ref-type="table"} presents the results of the analysis of the impact of public and private healthcare expenditure on the incidence of tuberculosis per 100,000 people. The empirical evidence shows a strong negative and statistically significant relationship between healthcare expenditure and tuberculosis. Panel A shows that public healthcare expenditure has a higher association with tuberculosis than private expenditure. Therefore, a policy that increases public health expenditure is associated with a decline in tuberculosis per 100,000. Panel B shows the relationship between private healthcare expenditure and a reduction in tuberculosis per 100,000 people in the average country. The results reveal there is a negative relationship between private expenditure and tuberculosis. The beta coefficient for public expenditure is statistically significant at 1%, and for private expenditure, it is significant at 10%. Pairwise correlation also supports the negative relationship between healthcare spending and the incidence of tuberculosis. The Hausman test reveals that the random method is better since prob\>chi2 is above 5%.

Conclusion
==========

This study investigates the association between public and private healthcare expenditure on the health status of people in eight selected African countries. The study used yearly data from 2000 to 2014 and employed two popular methods, random and fixed effect. The empirical analysis resulted in several findings. There is a negative correlation between both public and private healthcare expenditure and incidence of tuberculosis, adult male and female mortality rates, maternal deaths and the prevalence of HIV. Comparing the impact of public and private healthcare expenditure to the quality of wellbeing, we found that public healthcare expenditure had a greater impact than private healthcare expenditure on all variables except for maternal deaths, where the impact of private expenditure was double that of public expenditure. The results are robust and statistically significant in nearly all regressions. In general, our findings reveal that an increase in public healthcare spending will lead to a reduction in female morality, male mortality, number of maternal deaths, incidence of tuberculosis and prevalence of HIV. We found private healthcare expenditure to be gender-sensitive, with male mortality being impacted more significantly than female mortality.

In conclusion, the above findings convey an essential policy message that should be considered by selected African countries. Our findings show that public healthcare spending improves health status, and it is therefore important for policy makers to pay attention to allocating funds to the healthcare sector. The above finding calls for the eight selected African countries to pay more attention to public healthcare expenditure in order to improve health status, especially since private healthcare creates an extra burden for the poor to access healthcare facilities. In this regard, future research should focus on analyzing components of private healthcare spending such as direct household out-of-pocket spending, private insurance and direct service payments by private corporations as dependent variables to understand what form of private investment should be encouraged. In addition, future research may also concentrate on investigating other health outcome variables for all Sub- Saharan African countries, using recent data and possibly include in the model the number of physicians, number of hospital beds and literacy rates.
